KIDS logo

OrthoPediatrics Corp. (KIDS)

$31.50

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on KIDS

Market cap

$822479994

EPS

-1.43

P/E ratio

--

Price to sales

2.24

Dividend yield

--

Beta

0.902066

Price on KIDS

Previous close

$32.35

Today's open

$32.16

Day's range

$31.32 - $32.35

52 week range

$14.42 - $34.53

Profile about KIDS

CEO

David R. Bailey

Employees

602

Headquarters

Warsaw, IN

Exchange

NASDAQ Global Market

Shares outstanding

26110476

Issue type

Common Stock

KIDS industries and sectors

Healthcare

Medical Equipment & Supplies

News on KIDS

OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System

Successful Limited Launch Highlights Strong Demand and Adoption of the Company's Innovative Early Onset Scoliosis Solution Successful Limited Launch Highlights Strong Demand and Adoption of the Company's Innovative Early Onset Scoliosis Solution

news source

GlobeNewsWire • Nov 9, 2026

news preview

OrthoPediatrics to Participate in Upcoming Conferences

WARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY.

news source

GlobeNewsWire • Nov 2, 2026

news preview

All You Need to Know About OrthoPediatrics (KIDS) Rating Upgrade to Buy

OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Oct 30, 2026

news preview

OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript

OrthoPediatrics Corp. ( KIDS ) Q3 2026 Earnings Call October 27, 2026 4:30 PM EDT Company Participants David Bailey - President, CEO & Director Fred Hite - CFO, Principal Financial & Accounting Officer, COO and Director Conference Call Participants Philip Taylor - Gilmartin Group LLC Caitlin Roberts - Canaccord Genuity Corp., Research Division Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Matson - Needham & Company, LLC, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to OrthoPediatrics Corporation's Third Quarter 2026 Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

news source

Seeking Alpha • Oct 28, 2026

news preview

OrthoPediatrics: 3 Key Takeaways for Long-Term Investors

OrthoPediatrics raised 2026 revenue guidance to $270 million to $273 million. Third-quarter revenue grew 19% year over year to $72.7 million.

news source

The Motley Fool • Oct 28, 2026

news preview

OrthoPediatrics Q3 Earnings Call Highlights

OrthoPediatrics NASDAQ: KIDS reported record third-quarter revenue and raised its full-year sales outlook, citing broad-based demand across its trauma, deformity, scoliosis and specialty bracing businesses, as well as continued progress from recently introduced products.

news source

MarketBeat • Oct 28, 2026

news preview

OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance

Record  Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year

news source

GlobeNewsWire • Oct 27, 2026

news preview

OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.24 per share a year ago.

news source

Zacks Investment Research • Oct 27, 2026

news preview

OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations

New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction

news source

GlobeNewsWire • Oct 27, 2026

news preview

OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026

WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results.

news source

GlobeNewsWire • Oct 13, 2026

news preview

¹ Disclosures

Get started with M1

Invest in OrthoPediatrics Corp.

Open an M1 investment account to buy and sell OrthoPediatrics Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in KIDS on M1